BiologicalActivity
PotentJAKinhibitor(IC50valuesare1,20,and112nMforJAK3,JAK2andJAK1respectively).Orallyactiveimmunosuppressant;exhibitsefficacyinrodentrheumatoidarthritismodels.
LicensingInformation
SoldforresearchpurposesunderagreementfromPfizerInc.
ExternalPortalInformation
Chemicalprobes.orgisaportalthatoffersindependentguidanceontheselectionand/orapplicationofsmallmoleculesforresearch.TheuseofCP690550(Tofacitinib)isreviewedonthechemicalprobeswebsite.
CompoundLibraries
CP690550citrateisalsoofferedaspartoftheTocriscreenPlusandTocriscreenKinaseInhibitorToolboxII.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
TechnicalData
M.Wt | 504.49 |
Formula | C16H20N6O.C6H8O7 |
Storage | Storeat+4°C |
Purity | ≥99%(HPLC) |
CASNumber | 540737-29-9 |
PubChemID | 10174505 |
InChIKey | SYIKUFDOYJFGBQ-YLAFAASESA-N |
Smiles | C[C@H]1[C@@H](N(C2=NC=NC3=C2C=CN3)C)CN(C(CC#N)=O)CC1.OC(CC(O)=O)(C(O)=O)CC(O)=O |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
SolubilityData
Solvent | MaxConc.mg/mL | MaxConc.mM | |
---|---|---|---|
Solubility | |||
DMSO | 50.45 | 100 |
PreparingStockSolutions
Thefollowingdataisbasedontheproductmolecularweight504.49.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
---|---|---|---|
1mM | 1.98mL | 9.91mL | 19.82mL |
5mM | 0.4mL | 1.98mL | 3.96mL |
10mM | 0.2mL | 0.99mL | 1.98mL |
50mM | 0.04mL | 0.2mL | 0.4mL |